Best Poster Award Winners

ICNMD2018 wishes to congratulate the Best Poster Award Winners as per listed below:

Topic Group 1 – Muscle Diseases of Genetic Origin and Acquired Myopathies: Clinical Features, Pathophysiology, Therapy

PS1Group1-064: BREATHING IS LIFE! INSPIRATORY MUSCLE TRAINING IN CHILDREN AND ADOLESCENTS LIVING WITH NEUROMUSCULAR DISEASES
Anri Human1, Jennifer Jelsma2, Brenda M. Morrow3
1Physiotherapy, Sefako Makgatho Health Sciences University, Garankuwa, , ZA;2Division Physiotherapy, University of Cape Town, Observatory, ZA;3Paediatrics And Child Health, University of Cape Town, Rondebosch, ZA

Topic Group 2 – Diseases of Neuromuscular Junction: Clinical Features, Pathophysiology, Therapy

PS3Group2-026: FETAL ACETYLCHOLINE RECEPTOR INACTIVATION SYNDROME: A RARE, BUT POTENTIALLY TREATABLE CAUSE OF FAMILIAL MYOPATHY
Doris Nguyen1, Stephan Botez2, Cam-Tu Emilie Nguyen3
1CHU Sainte-Justine, Montreal, QC, CA;2Neurology, CHUM, Montreal, QC, CA;3Pediatric Neurology, CHU Sainte-Justine, Montreal, QC, CA

Topic Group 3 – Peripheral Neuropathy, Cranial Nerves, Mononeuropathies: Clinical Features, Pathophysiology, Therapy

PS2Group3-026: PUTATIVE DIGENIC INHERITANCE OF CHARCOT-MARIE-TOOTH DISEASE INVOLVING TWO NOVEL HETEROZYGOUS MUTATIONS IN MARS AND HARS
Martin Krenn1, Anna Grisold1, Gudrun Zulehner1, Jakob Rath1, Hakan Cetin1, Matthias Tomschik1, Bojan Zagrovic2, Lukas Bartonek2, Tomislav Kokotovic3, Vanja Nagy3, Matias Wagner4, Tim M. Strom4, Fritz Zimprich1
1Department of Neurology, Medical University of Vienna, Vienna, AT;2Department of Structural And Computational Biology, Max F. Perutz Laboratories, University of Vienna, Vienna, AT;3Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, AT;4Institute of Human Genetics, Technical University Munich, Munich, DE

Topic Group 4 – Motor Neuron Diseases: Clinical Features, Pathophysiology, Therapy

PS3Group4-006: EXPLORATION OF THE REPOSITIONING POTENTIAL OF MARKETED DRUGS FOR NEUROPATHIES
Jacqueline Gide1, Florine Roussange2, Hélène Polvèche1, Didier Auboeuf3, Anne Boland4, Jean-François Deleuze4, Borckman Knut5, Johanna Tournois1, Marc Peschanski6, Cecile Martinat7, Sandrine Baghdoyan2
1I-stem, CECS, CORBEIL ESSONNES, FR;2Motor Neurone Disease, INSERM/UEVE UMR 861, I-STEM, Corbeil-Essonnes, FR;3Laboratoire De Biologie Et Modélisation De La Cellule,, ENS de Lyon, Lyon, FR;4Centre National De Genotypage, CEA, EVRY, FR;5Interdisciplinary Pediatric center for children with developmental disabilitiesand severe chronic disorders,, Gottingen, DE;6I-stem Cecs, INSERM UEVE UMR861, CORBEIL ESSONNES, FR;7I-stem, INSERM UEVE UMR861, CORBEIL ESSONNES, FR

Topic Group 5 – Novel Diagnostic Methods in Neuromuscular Diseases and Basic Sciences in Neuromuscular Diseases

PS2Group5-004: LABEL-FREE IMAGING OF ABNORMAL LIPID ACCUMULATION IN PERIPHERAL NERVES FROM FABRY DISEASE PATIENTS USING RAMAN SPECTROSCOPY
Yu Nagashima1, Atsushi Iwata1, Kosuke Yoshioka2, Junko Omachi3, Jun Shimizu1, Tatsuhi Toda1, Junji Yumoto3, Makoto K. Gonokami4
1Department of Neurology, The University of Tokyo Hospital, Tokyo, JP;2School of Engineering, The University of Tokyo, Tokyo, JP;3School of Science, The University of Tokyo, Tokyo, JP;4The University of Tokyo, Tokyo, JP

Topic Group 6 – Cancer related Disorders and General Diseases

PS2Group6-003: PEDIATRIC EXTRADURAL COMPRESSIVE MYELOPATHY SECONDARY TO GANGLIONEUROBLASTOMA; NERVE ROOTS AND BRACHIAL PLEXUS BEWARE
Amanda Yaworski1, Ratika Srivastava1, Vivek Mehta2, Atilano Lacson3, Hanna Kolski1
1Pediatric Neurology, University of Alberta, Edmonton, CA;2Neurosurgery, University of Alberta, Edmonton, CA;3Pathology, University of Alberta, Edmonton, CA

Topic Group 7 – Patient Related Issues

PS3Group7-004: PATIENT PERSPECTIVES ON THE SIDE EFFECT BURDEN OF TREATMENTS FOR MYASTHENIA GRAVIS (MG) AND THEIR IMPACT ON DAILY LIFE
Elizabeth D. Bacci1, Karin S. Coyne1, Linda Harris2, Jiat-Ling Poon3, Audra N. Boscoe4
1Business Unit of Ppd, Evidera, Bethesda, MD, US;2Alexion Pharmaceuticals, New Haven, US;3Lilly Corporate Center, Eli Lilly and Company, Indianapolis, IN, US;4Agios Pharmaceuticals, Cambridge, MA, US

Topic Group 9 – Miscellaneous

PS2Group9-013: AAV-ASSOCIATED SENSORY GANGLIONITIS AND AXONOPATHY IN LABORATORY ANIMALS: A RETROSPECTIVE STUDY
Juliette Hordeaux, Elizabeth L. Buza, Laura Richman, Christian Hinderer, Nathan Katz, Peter Bell, James M. Wilson
Gene Therapy Program, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, US

Conference Newsletter

Close

Subscribe to the Newsletter to receive important information about the upcoming Conference.